Linagliptin

Post Date:
Oct 06,2013
Expiry Date:
Oct 06,2014
Detailed Description:
Cas No. :668270-12-0 Linagliptin is an Inhibitor of dipeptidyl peptidase 4, it is a member of the “Gliptin” class of oral hypoglycemics that block DPP-4. They can be used to treat diabetes mellitus type 2.

Linagliptin was approved by the US FDA in 2011
CAS Registry Number:
668270-12-0
Synonyms:
;8-[(3R)-3-Amino-1-piperidinyl]-7-(2-butynyl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione;8-[(3R)-3-aminopiperidin-1-yl]-7-(but-2-yn-1-yl)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1H-purine-2,6-dione;1h-purine-2,6-dione, 8-[(3r)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-;
Molecular Formula:
C₂₅H₂₈N₈O₂
Molecular Weight:
472.5422
Molecular Structure:

Offter to Sell